GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Torii Pharmaceutical Co Ltd (OTCPK:TRXPF) » Definitions » Cyclically Adjusted Revenue per Share

Torii Pharmaceutical Co (Torii Pharmaceutical Co) Cyclically Adjusted Revenue per Share : $12.39 (As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Torii Pharmaceutical Co Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Torii Pharmaceutical Co's adjusted revenue per share for the three months ended in Mar. 2024 was $3.195. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $12.39 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Torii Pharmaceutical Co's average Cyclically Adjusted Revenue Growth Rate was 1.30% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 1.40% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 0.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Torii Pharmaceutical Co was 1.40% per year. The lowest was -0.30% per year. And the median was 0.50% per year.

As of today (2024-06-19), Torii Pharmaceutical Co's current stock price is $24.57. Torii Pharmaceutical Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was $12.39. Torii Pharmaceutical Co's Cyclically Adjusted PS Ratio of today is 1.98.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Torii Pharmaceutical Co was 2.10. The lowest was 1.04. And the median was 1.49.


Torii Pharmaceutical Co Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Torii Pharmaceutical Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Torii Pharmaceutical Co Cyclically Adjusted Revenue per Share Chart

Torii Pharmaceutical Co Annual Data
Trend Mar14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.78 15.64 17.52 17.13 14.25

Torii Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.71 13.87 13.06 14.25 12.39

Competitive Comparison of Torii Pharmaceutical Co's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Torii Pharmaceutical Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Torii Pharmaceutical Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Torii Pharmaceutical Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Torii Pharmaceutical Co's Cyclically Adjusted PS Ratio falls into.



Torii Pharmaceutical Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Torii Pharmaceutical Co's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=3.195/107.2000*107.2000
=3.195

Current CPI (Mar. 2024) = 107.2000.

Torii Pharmaceutical Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 4.286 98.000 4.688
201409 4.761 98.500 5.182
201412 4.931 97.900 5.399
201503 3.903 97.900 4.274
201506 4.609 98.400 5.021
201509 4.531 98.500 4.931
201512 5.094 98.100 5.567
201603 4.299 97.900 4.707
201606 5.123 98.100 5.598
201609 5.122 98.000 5.603
201612 5.019 98.400 5.468
201703 4.297 98.100 4.696
201706 5.298 98.500 5.766
201709 5.032 98.800 5.460
201712 5.811 99.400 6.267
201803 4.683 99.200 5.061
201806 5.382 99.200 5.816
201809 4.761 99.900 5.109
201812 5.401 99.700 5.807
201903 2.937 99.700 3.158
201906 3.799 99.800 4.081
201909 3.523 100.100 3.773
201912 3.812 100.500 4.066
202003 3.167 100.300 3.385
202006 3.404 99.900 3.653
202009 3.478 99.900 3.732
202012 3.952 99.300 4.266
202103 3.243 99.900 3.480
202106 3.768 99.500 4.060
202109 3.840 100.100 4.112
202112 4.237 100.100 4.538
202203 3.290 101.100 3.489
202206 3.226 101.800 3.397
202209 3.033 103.100 3.154
202212 3.582 104.100 3.689
202303 3.145 104.400 3.229
202306 3.496 105.200 3.562
202309 3.233 106.200 3.263
202312 3.831 106.800 3.845
202403 3.195 107.200 3.195

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Torii Pharmaceutical Co  (OTCPK:TRXPF) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Torii Pharmaceutical Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=24.57/12.39
=1.98

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Torii Pharmaceutical Co was 2.10. The lowest was 1.04. And the median was 1.49.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Torii Pharmaceutical Co Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Torii Pharmaceutical Co's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Torii Pharmaceutical Co (Torii Pharmaceutical Co) Business Description

Traded in Other Exchanges
Address
Torii Nihonbashi Buildingg, 4-1, Nihonbashi-Honcho, 3-chome, Chuo-ku, Tokyo, JPN, 103-8439
Torii Pharmaceutical Co Ltd is a major drug manufacturing company. The company utilizes strategic partnerships with other pharmaceutical companies in order to combine research and marketing functions. Torii's key therapeutic areas include renal diseases, hemodialysis, HIV, skin diseases, and allergens. The vast majority of the company's net mainstay product sales are derived from the renal diseases and hemodialysis operations, followed by HIV. Torii's places its strategic focus on prompt market penetration and expansion of new products as well as maximizing values of mainstay products in each priority area.

Torii Pharmaceutical Co (Torii Pharmaceutical Co) Headlines

No Headlines